Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1842 News Items found Equipped for Discovery Wednesday, November 14, 2012 Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies. Event Webcast of 2012 Major Trends in Modern Cancer Research Tuesday, November 6, 2012 For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world. Q&A At Work: Physician-Scientist Ping Chi Friday, November 2, 2012 Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer. Scott Armstrong and Kitai Kim Named to Endowed Chairs Thursday, November 1, 2012 Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair. Announcement Pioneering Cancer Research Complex Nears Completion Wednesday, October 17, 2012 Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer. In the Lab Memorial Sloan Kettering Investigators Synthesize Vital Biological Molecule Erythropoietin for the First Time Monday, October 8, 2012 Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells. Announcement Alexander Rudensky Appointed Immunology Program Chair Wednesday, September 26, 2012 Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009. Snapshot Tunneling Nanotubes Connect Cancer Cells Wednesday, September 19, 2012 Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes. In the Lab Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective Thursday, September 6, 2012 Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms. In the Lab Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia Tuesday, September 4, 2012 In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment